| Bioactivity | CDK7-IN-31 (compound 13) is a potent and orally active cyclin-dependent kinase 7 (CDK7) inhibitor with a Kd value of 0.18 nM. CDK7-IN-31 shows anticancer activity[1]. |
| CAS | 2943043-62-5 |
| Formula | C27H32F5N6O2P |
| Molar Mass | 598.55 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lu H, et al. Discovery of a Novel Macrocyclic Noncovalent CDK7 Inhibitor for Cancer Therapy. J Med Chem. 2024 Nov 9. |
CDK7-IN-31
CAS: 2943043-62-5 F: C27H32F5N6O2P W: 598.55
CDK7-IN-31 (compound 13) is a potent and orally active cyclin-dependent kinase 7 (CDK7) inhibitor with a Kd value of 0.1
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.